HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Litwak, R. S. Articles by Lajam, F. A. Search for Related Content PubMed PubMed Citation Articles by Litwak, R. S. Articles by Lajam, F. A.

The Annals of Thoracic Surgery, Vol 21, 191-202, Copyright © 1976 by The Society of Thoracic Surgeons

ARTICLES

Use of a left heart assist device after intracardiac surgery: technique and clinical experience

RS Litwak, RM Koffsky, RA Jurado, SB Lukban, AF Ortiz, AP Fischer, JJ Sherman, G Silvay and FA Lajam

A left heart assist device (LHAD) has been employed in 14 patients. All had advanced heart disease and were in low cardiac output after repair, such that they could not be separated from cardiopulmonary bypass despite prolonged support and adjuvant therapy, including drugs, pacing, and use of intraaortic balloon counterpulsation whenever possible. Apart from special cannulas, the equipment necessary for the LHAD is widely available. An asset of the system (left atrial-ascending aorta bypass of the left ventricle) is that it may be terminated without reentering the thorax to remove the cannulas. This is accomplished with precisely fitting obturators that obliterate the cannula lumens and allow the tubes to be permanently implanted. This concept is believed important since critically ill patients requiring support are precisely those in whom added risk would be imposed by a second operation. Of the 14 patients who have had intraoperative and postoperative support (up to 6.8 days), 9 were weaned from the device and 6 were dismissed from the hospital. Four patients remain alive and are improved, the longest at 22 months since operation. The favorable performance of the LHAD suggests that it may prove useful either when intraaortic balloon counterpulsation cannot be successfully deployed or when it has failed to achieve hemodynamic stability.

This article has been cited by other articles:

				M. S. Slaughter, S. S. Tsui, A. El-Banayosy, B. C. Sun, R. L. Kormos, D. K. Mueller, H. T. Massey, T. B. Icenogle, D. J. Farrar, J. D. Hill, et al. Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1573 - 1580. [Abstract] [Full Text] [PDF]

				H. Takano and T. Nakatani Ventricular Assist Systems: Experience in Japan With Toyobo Pump and Zeon Pump Ann. Thorac. Surg., January 1, 1996; 61(1): 317 - 322. [Abstract] [Full Text]

				J. A Odell, U. von Oppell, H. Reichenspurner, A. Macdonald, D. Boehm, S. Tate, and B. Reichart Left heart assist device: a simple method to conserve associated blood loss Perfusion, July 1, 1988; 3(3): 213 - 217. [PDF]

				G. Uretzky, G. Landsburg, D. Cohn, Y. Wax, and J. B Borman Analysis of microembolic particles originating in extracorporeal circuits Perfusion, January 1, 1987; 2(1): 9 - 17. [Abstract] [PDF]

				A. May Current Status of Coronary Surgery Angiology, December 1, 1977; 28(12): 879 - 884. [PDF]